Eric Verdin, MD

Eric Verdin, MD

Advisory Board

Dr. Verdin is the president and chief executive officer of the Buck Institute for Research on Aging.

He studies how metabolism, diet, and small molecules regulate the activity of HDACs and sirtuins, and thereby the aging process and its associated diseases, including Alzheimer’s.

He has published more than 270 scientific papers and holds more than 18 patents. He is an elected member of several scientific organizations, including the American Association for the Advancement of Science, the American Society for Clinical Investigation, and the Association of American Physicians. He also serves on the advisory council of National Institute on Drug Abuse at the National Institutes of Health.

Dr. Verdin has extensive experience working with biotech companies. He is a founder of Acylin (purchased by Abbvie). He served on the scientific advisory boards of Elixir, Sirtris (purchased by GSK), Calico (Google), and Nokia, and he also served as advisor to Sofinnova Ventures.

ask ai about us
ChatGPT
ChatGPT
Claude
Claude